Full Text
Cost-Effectiveness in England of Cabozantinib for Patients with Advanced Renal Cell Carcinoma (ARCC) After Failure of Prior Therapy

Abstract

Authors

J Lister A Vataire B Amzal J Dinet J Meng H Karcher S Gabriel

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×